We came across a bullish thesis on Alvotech on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on ALVO. Alvotech's share was trading at $4.60 as of December 2nd. ALVO’s trailing and forward P/E were 21.04 and 10.02 respectively according to Yahoo Finance.
[caption id="attachment_575381" align="aligncenter" width="750"]Alvotech is positioning itself as the “TSMC of biologics”—a fully integrated, globally compliant biosimilar manufacturer built around process control, regulatory trust, and scale...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.